{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:07:48Z","timestamp":1792638468910,"version":"4.5.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.berh.2009.07.007","type":"journal-article","created":{"date-parts":[[2009,10,24]],"date-time":"2009-10-24T04:55:42Z","timestamp":1256360142000},"page":"665-678","source":"Crossref","is-referenced-by-count":108,"title":["Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment"],"prefix":"10.1016","volume":"23","author":[{"given":"Lucy R.","family":"Wedderburn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa G.","family":"Rider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2009.07.007_bib1","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1002\/art.23960","article-title":"Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features","volume":"58","author":"Stringer","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/art.23299","article-title":"Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis","volume":"58","author":"Christen-Zaech","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib3","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/rheumatology\/34.8.732","article-title":"The incidence of juvenile dermatomyositis: results from a nation-wide study","volume":"34","author":"Symmons","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.berh.2009.07.007_bib4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/art.11122","article-title":"US incidence of juvenile dermatomyositis, 1995\u20131998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry","volume":"49","author":"Mendez","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib5","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/rheumatology\/kel099","article-title":"The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)\u2013clinical characteristics of children recruited within the first 5 yr","volume":"45","author":"McCann","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2009.07.007_bib6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S1521-6942(04)00015-4","article-title":"Paediatric idiopathic inflammatory muscle disease","volume":"18","author":"Wedderburn","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.berh.2009.07.007_bib7","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/art.21068","article-title":"History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry","volume":"53","author":"Pachman","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib8","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/S0140-6736(08)60955-1","article-title":"Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood","volume":"371","author":"Feldman","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2009.07.007_bib9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.berh.2009.07.007_bib10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/rheumatology\/keh130","article-title":"Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis","volume":"43","author":"Maillard","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2009.07.007_bib11","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/rheumatology\/kel025","article-title":"An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM)","volume":"45","author":"Brown","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2009.07.007_bib12","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/art.23012","article-title":"International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials","volume":"57","author":"Wedderburn","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib13","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1002\/art.21291","article-title":"International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies","volume":"52","author":"Oddis","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1146\/annurev.immunol.021908.132653","article-title":"Recent advances in the genetics of autoimmune disease","volume":"27","author":"Gregersen","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.berh.2009.07.007_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/08916930600622819","article-title":"National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary\u2013clinical characteristics and disease course of 44 patients with juvenile dermatomyositis","volume":"39","author":"Constantin","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.berh.2009.07.007_bib16","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1002\/art.24039","article-title":"Cytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis","volume":"58","author":"Mamyrova","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib17","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(77)90487-1","article-title":"Increased frequency of HLA-B8 in juvenile dermatomyositis","volume":"2","author":"Pachman","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2009.07.007_bib18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0198-8859(91)90085-N","article-title":"Molecular genetic studies of major histocompatibility complex genes in children with juvenile dermatomyositis: increased risk associated with HLA-DQA1 *0501","volume":"32","author":"Reed","year":"1991","journal-title":"Hum Immunol"},{"key":"10.1016\/j.berh.2009.07.007_bib19","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1002\/art.22216","article-title":"Immunogenetic risk and protective factors for juvenile dermatomyositis in Caucasians","volume":"54","author":"Mamyrova","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib20","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/rheumatology\/kem265","article-title":"HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis\u2013scleroderma overlap","volume":"46","author":"Wedderburn","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2009.07.007_bib21","doi-asserted-by":"crossref","unstructured":"Chinoy H, Payne D, Poulton K, et\u00a0al. HLA-DPB1 associations differ between DRB1*03 positive anti-Jo-1 and anti-PMScl antibody positive idiopathic inflammatory myopathy. Rheumatology, in press, doi:10.1093\/rheumatology\/kep248.","DOI":"10.1093\/rheumatology\/kep248"},{"key":"10.1016\/j.berh.2009.07.007_bib22","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/1529-0131(200010)43:10<2368::AID-ANR26>3.0.CO;2-8","article-title":"TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications","volume":"43","author":"Pachman","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib23","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1002\/art.23900","article-title":"The protein tyrosine phosphatase N22 gene is associated with juvenile and adult idiopathic inflammatory myopathy independent of the HLA 8.1 haplotype in British Caucasian patients","volume":"58","author":"Chinoy","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib24","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1002\/art.23899","article-title":"Immunoglobulin gene polymorphisms are susceptibility factors in clinical and autoantibody subgroups of the idiopathic inflammatory myopathies","volume":"58","author":"O'Hanlon","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib25","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1073\/pnas.94.7.3195","article-title":"Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation","volume":"94","author":"Wilson","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.berh.2009.07.007_bib26","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/rheumatology\/kem145","article-title":"Tumour necrosis factor-alpha single nucleotide polymorphisms are not independent of HLA class I in UK Caucasians with adult onset idiopathic inflammatory myopathies","volume":"46","author":"Chinoy","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2009.07.007_bib27","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/rheumatology\/ken038","article-title":"Assessment of an infectious disease history preceding juvenile dermatomyositis symptom onset","volume":"47","author":"Manlhiot","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2009.07.007_bib28","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/art.1780381019","article-title":"Lack of detection of enteroviral RNA or bacterial DNA in magnetic resonance imaging-directed muscle biopsies from twenty children with active untreated juvenile dermatomyositis","volume":"38","author":"Pachman","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib29","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1001\/jama.294.17.2170","article-title":"Parvovirus B19 and onset of juvenile dermatomyositis","volume":"294","author":"Mamyrova","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.berh.2009.07.007_bib30","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1002\/art.22751","article-title":"Seasonal birth patterns in myositis subgroups suggest an etiologic role of early environmental exposures","volume":"56","author":"Vegosen","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib31","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0889-857X(05)70350-1","article-title":"Classification and treatment of the juvenile idiopathic inflammatory myopathies","volume":"23","author":"Rider","year":"1997","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.berh.2009.07.007_bib32","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/rheumatology\/kep078","article-title":"Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression","volume":"48","author":"Gunawardena","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2009.07.007_bib33","first-page":"1794","article-title":"Clinical significance of specific autoantibodies in juvenile dermatomyositis","volume":"23","author":"Feldman","year":"1996","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2009.07.007_bib34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/01.md.0000217525.82287.eb","article-title":"Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies","volume":"85","author":"O'Hanlon","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.berh.2009.07.007_bib35","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/art.22164","article-title":"A novel autoantibody to a 155-kd protein is associated with dermatomyositis","volume":"54","author":"Targoff","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib36","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/rheumatology\/kem359","article-title":"Clinical associations of autoantibodies to a p155\/140 kDa doublet protein in juvenile dermatomyositis","volume":"47","author":"Gunawardena","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2009.07.007_bib37","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/MD.0b013e31816bc604","article-title":"Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity","volume":"87","author":"Bingham","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.berh.2009.07.007_bib38","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/art.24547","article-title":"Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis","volume":"60","author":"Gunawardena","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib39","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1084\/jem.20041367","article-title":"Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy","volume":"201","author":"Casciola-Rosen","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.berh.2009.07.007_bib40","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.20020186","article-title":"Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells","volume":"196","author":"Howard","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.berh.2009.07.007_bib41","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1002\/art.22860","article-title":"A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52\/anti-Ro 60 autoantibodies","volume":"56","author":"Eloranta","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib42","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.4049\/jimmunol.168.8.4154","article-title":"Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis","volume":"168","author":"Tezak","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.berh.2009.07.007_bib43","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.clim.2006.05.011","article-title":"MxA gene expression in juvenile dermatomyositis peripheral blood mononuclear cells: association with muscle involvement","volume":"120","author":"O'Connor","year":"2006","journal-title":"Clin Immunol"},{"key":"10.1016\/j.berh.2009.07.007_bib44","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/art.22993","article-title":"Predictability of the clinical course of juvenile dermatomyositis based on initial muscle biopsy: a retrospective study of 72 patients","volume":"57","author":"Miles","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib45","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ana.410270402","article-title":"Microvascular changes in early and advanced dermatomyositis: a quantitative study","volume":"27","author":"Emslie-Smith","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.berh.2009.07.007_bib46","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/art.1780400514","article-title":"Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies","volume":"40","author":"Lundberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib47","first-page":"801","article-title":"Immunohistochemical analysis of adhesion molecule expression on muscle biopsy specimens from patients with juvenile dermatomyositis","volume":"31","author":"Sallum","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2009.07.007_bib48","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1002\/art.21303","article-title":"Association between lack of angiogenic response in muscle tissue and high expression of angiostatic ELR-negative CXC chemokines in patients with juvenile dermatomyositis: possible link to vasculopathy","volume":"52","author":"Fall","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib49","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1740-2557-3-2","article-title":"Endothelial cell activation and neovascularization are prominent in dermatomyositis","volume":"3","author":"Nagaraju","year":"2006","journal-title":"J\u00a0Autoimmune Dis"},{"key":"10.1016\/j.berh.2009.07.007_bib50","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2119\/2006-00085.Baechler","article-title":"An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity","volume":"13","author":"Baechler","year":"2007","journal-title":"Mol Med"},{"key":"10.1016\/j.berh.2009.07.007_bib51","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/art.22558","article-title":"Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis","volume":"56","author":"Lopez de Padilla","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib52","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/art.24411","article-title":"Extranodal lymphoid microstructures in inflamed muscle and disease severity of new-onset juvenile dermatomyositis","volume":"60","author":"Lopez De Padilla","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib53","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.4049\/jimmunol.172.8.5041","article-title":"Does HLA-dependent chimerism underlie the pathogenesis of juvenile dermatomyositis?","volume":"172","author":"Reed","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.berh.2009.07.007_bib54","first-page":"605","article-title":"MHC Class I overexpression on muscles in early juvenile dermatomyositis","volume":"31","author":"Li","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2009.07.007_bib55","doi-asserted-by":"crossref","first-page":"9209","DOI":"10.1073\/pnas.97.16.9209","article-title":"Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies","volume":"97","author":"Nagaraju","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.berh.2009.07.007_bib56","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/mus.21129","article-title":"Upregulation of MHC class I in transgenic mice results in reduced force-generating capacity in slow-twitch muscle","volume":"39","author":"Salomonsson","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.berh.2009.07.007_bib57","doi-asserted-by":"crossref","unstructured":"Li C, Knopp P, Moncrieffe H, et\u00a0al. Over expression of MHC class l heavy chain protein in young skeletal muscle leads to severe myositis: implications for juvenile myositis. Am J Pathol, in press, doi:10.2353\/ajpath.2009.090196.","DOI":"10.2353\/ajpath.2009.090196"},{"key":"10.1016\/j.berh.2009.07.007_bib58","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/rheumatology\/40.11.1262","article-title":"Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies","volume":"40","author":"Miller","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2009.07.007_bib59","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/rheumatology\/keg403","article-title":"Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis","volume":"42","author":"Ruperto","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2009.07.007_bib60","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/art.23248","volume":"59","author":"Ruperto","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib61","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1002\/art.20349","article-title":"International consensus on preliminary definitions of improvement in adult and juvenile myositis","volume":"50","author":"Rider","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"S","key":"10.1016\/j.berh.2009.07.007_bib62","first-page":"S534","article-title":"The validated PRINTO core set and definition of improvement for juvenile myositis","volume":"50","author":"Ruperto","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib63","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/08916930600622553","article-title":"Clinical assessment in juvenile dermatomyositis","volume":"39","author":"Ravelli","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.berh.2009.07.007_bib64","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/rheumatology\/kem179","article-title":"The Cutaneous Assessment Tool: development and reliability in juvenile idiopathic inflammatory myopathy","volume":"46","author":"Huber","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2009.07.007_bib65","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/art.23340","article-title":"Preliminary validation and clinical meaning of the Cutaneous Assessment Tool in juvenile dermatomyositis","volume":"59","author":"Huber","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib66","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/art.23313","article-title":"Alternative scoring of the Cutaneous Assessment Tool in juvenile dermatomyositis: results using abbreviated formats","volume":"59","author":"Huber","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib67","first-page":"1","article-title":"Photoessay of the cutaneous manifestations of the idiopathic inflammatory myopathies","volume":"15","author":"Dugan","year":"2009","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.berh.2009.07.007_bib68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.10924","article-title":"Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence","volume":"49","author":"Bode","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib69","first-page":"1644","article-title":"Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops","volume":"31","author":"Smith","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2009.07.007_bib70","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/art.23341","article-title":"Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with juvenile dermatomyositis","volume":"59","author":"Rouster-Stevens","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib71","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2133.2007.08342.x","article-title":"Development and validation of the Dermatomyositis Skin Severity Index","volume":"158","author":"Carroll","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.berh.2009.07.007_bib72","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1365-2133.2008.08711.x","article-title":"Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis","volume":"159","author":"Klein","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.berh.2009.07.007_bib73","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/art.24343","article-title":"Health-related quality of life of patients with juvenile dermatomyositis: results from the Pediatric Rheumatology International Trials Organisation multinational quality of life cohort study","volume":"61","author":"Apaz","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib74","unstructured":"Rider LG, Lachenbruch PA, Monroe JB, et\u00a0al. Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis using the myositis damage index. Arthritis Rheum, in press."},{"key":"10.1016\/j.berh.2009.07.007_bib75","first-page":"S830","article-title":"The long-term outcome of juvenile idiopathic inflammatory myopathies: a multicenter, multinational study of 557 patients","volume":"52","author":"Traill","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"Suppl","key":"10.1016\/j.berh.2009.07.007_bib76","first-page":"S500","article-title":"Organ damage and prognostic factors in juvenile dermatomyositis","volume":"68","author":"Sanner","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2009.07.007_bib77","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/rheumatology\/kem131","article-title":"Oropharyngeal dysphagia in juvenile dermatomyositis (JDM): an evaluation of videofluoroscopy swallow study (VFSS) changes in relation to clinical symptoms and objective muscle scores","volume":"46","author":"McCann","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2009.07.007_bib78","doi-asserted-by":"crossref","unstructured":"Coyle K, Rother KI, Weise M, et\u00a0al. Metabolic abnormalities and cardiovascular risk factors in children with myositis. J\u00a0Paediatrics, in press, doi:10.2353\/ajpath.2009.090196.","DOI":"10.2353\/ajpath.2009.090196"},{"key":"10.1016\/j.berh.2009.07.007_bib79","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1002\/1529-0131(200008)43:8<1866::AID-ANR24>3.0.CO;2-6","article-title":"Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis. Implications for diagnosis and therapy","volume":"43","author":"Kimball","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib80","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0889-857X(02)00027-3","article-title":"Outcome assessment in the adult and juvenile idiopathic inflammatory myopathies","volume":"28","author":"Rider","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.berh.2009.07.007_bib81","first-page":"S922","article-title":"IL-17 and IFN-regulated genes and chemokines as biomarkers of disease activity in inflammatory myopathies","volume":"58","author":"Bilgic","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib82","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1517\/14656566.5.7.1509","article-title":"Treatment approaches to juvenile dermatomyositis","volume":"5","author":"Zipitis","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.berh.2009.07.007_bib83","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/art.21332","article-title":"Quantitative assessments of the effects of a single exercise session on muscles in juvenile dermatomyositis","volume":"53","author":"Maillard","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib84","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.2165\/00003495-200565100-00004","article-title":"Paediatric idiopathic inflammatory muscle disease: recognition and management","volume":"65","author":"Pilkington","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.berh.2009.07.007_bib85","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/art.24571","article-title":"Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment","volume":"60","author":"Kim","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib86","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1002\/art.21378","article-title":"The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids","volume":"52","author":"Ramanan","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib87","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/art.23829","article-title":"The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: a propensity score analysis","volume":"59","author":"Seshadri","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib88","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/rheumatology\/keh082","article-title":"Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis. A review of efficacy and safety","volume":"43","author":"Riley","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2009.07.007_bib89","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/rheumatology\/keh499","article-title":"Mycophenolate mofetil (CellCept): an alternative therapy for autoimmune inflammatory myopathy","volume":"44","author":"Majithia","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2009.07.007_bib90","first-page":"S680","article-title":"Mycophenolate mofetil in juvenile dermatomyositis","volume":"54","author":"Rouster-Stevens","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib91","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0140-6736(99)01927-3","article-title":"Tacrolimus in refractory polymyositis with interstitial lung disease","volume":"353","author":"Oddis","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2009.07.007_bib92","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s10067-008-0973-2","article-title":"Treatment of refractory juvenile dermatomyositis with tacrolimus","volume":"27","author":"Hassan","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2009.07.007_bib93","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/art.20849","article-title":"Rituximab in the treatment of dermatomyositis: an open-label pilot study","volume":"52","author":"Levine","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib94","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1002\/art.22856","article-title":"Rituximab for the treatment of juvenile dermatomyositis: a report of four pediatric patients","volume":"56","author":"Cooper","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib95","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/archderm.143.6.763","article-title":"A pilot trial of rituximab in the treatment of patients with dermatomyositis","volume":"143","author":"Chung","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.berh.2009.07.007_bib96","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1080\/10428190902934944","article-title":"The late adverse events of rituximab therapy\u2013rare but there!","volume":"50","author":"Ram","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.berh.2009.07.007_bib97","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/rheumatology\/ken074","article-title":"Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis","volume":"47","author":"Riley","year":"2008","journal-title":"Rheumatology"},{"issue":"Supplement","key":"10.1016\/j.berh.2009.07.007_bib98","first-page":"S306","article-title":"Use of Etanercept in chronic juvenile dermatomyositis","volume":"44","author":"Miller","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.07.007_bib99","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/ard.2007.077974","article-title":"A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies","volume":"67","author":"Dastmalchi","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2009.07.007_bib100","doi-asserted-by":"crossref","unstructured":"Holzer U, van Royen-Kerkhof, van der Torre P, et\u00a0al. Successful autologous stem cell transplantation in two patients with juvenile dermatomyositis. Scandinavian Journal of Rheumatology, in press, doi:10.1080\/03009740903096622","DOI":"10.1080\/03009740903096622"},{"key":"10.1016\/j.berh.2009.07.007_bib101","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.autrev.2006.08.009","article-title":"The heterogeneity of juvenile myositis","volume":"6","author":"Rider","year":"2007","journal-title":"Autoimmun Rev"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694209000801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694209000801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T06:27:31Z","timestamp":1558592851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694209000801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":101,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S1521694209000801"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2009.07.007","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}